Candel Therapeutics, Inc.CADLNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank50
Studio
Year-over-Year Change

Return on invested capital

Latest
-41.38%
↑ 12% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-46.79%
Historical baseline
PeriodValueYoY Change
2025-41.38%+1.1%
2024-41.82%+60.3%
2023-105.40%-122.7%
2022-47.33%-54.2%
2021-30.68%+24.4%
2020-40.58%-99.8%
2019-20.31%-